EdgarLookup

VYNE Therapeutics Inc. — 10-Q Filings

24 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by VYNE Therapeutics Inc. (VYNE), sorted by most recent first. Each row links to the full filing on EdgarLookup. VYNE Therapeutics Inc. has filed 24 10-Q documents with the SEC since 2013. To view all SEC filings by VYNE Therapeutics Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 4 4/A 424B2 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3 S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
10-Q 10-Q 0001566044-25-000010 Nov 6, 2025 Sep 30, 2025
10-Q 10-Q 0001628280-25-040366 Aug 14, 2025 Jun 30, 2025
10-Q 10-Q 0001628280-25-023740 May 8, 2025 Mar 31, 2025
10-Q 10-Q 0001628280-24-046244 Nov 7, 2024 Sep 30, 2024
10-Q 10-Q 0001628280-24-037176 Aug 14, 2024 Jun 30, 2024
10-Q 10-Q 0001628280-24-022183 May 9, 2024 Mar 31, 2024
10-Q 10-Q 0001628280-23-038414 Nov 13, 2023 Sep 30, 2023
10-Q 10-Q 0001628280-23-029334 Aug 14, 2023 Jun 30, 2023
10-Q 10-Q 0001628280-23-017583 May 11, 2023 Mar 31, 2023
10-Q 10-Q 0001628280-22-029836 Nov 14, 2022 Sep 30, 2022
10-Q 10-Q 0001628280-22-022687 Aug 12, 2022 Jun 30, 2022
10-Q 10-Q 0001628280-22-014092 May 12, 2022 Mar 31, 2022
10-Q 10-Q 0001566044-21-000037 Nov 10, 2021 Sep 30, 2021
10-Q 10-Q 0001566044-21-000034 Aug 12, 2021 Jun 30, 2021
10-Q 10-Q 0001566044-21-000025 May 6, 2021 Mar 31, 2021
10-Q 10-Q 0001566044-20-000022 Nov 5, 2020 Sep 30, 2020
10-Q 10-Q 0001566044-20-000011 Aug 6, 2020 Jun 30, 2020
10-Q FORM 10-Q 0001104659-20-059152 May 11, 2020 Mar 31, 2020
10-Q 10-Q 0001564590-19-039188 Oct 31, 2019 Sep 30, 2019
10-Q 10-Q 0001564590-19-027984 Aug 1, 2019 Jun 30, 2019
10-Q 10-Q 0001564590-19-015358 May 2, 2019 Mar 31, 2019
10-Q 10-Q 0001564590-18-028098 Nov 7, 2018 Sep 30, 2018
10-Q 10-Q 0001564590-18-018481 Aug 1, 2018 Jun 30, 2018
10-Q 10-Q 0001628280-18-006412 May 9, 2018 Mar 31, 2018